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years (22-84) left 69. All pts had multivascular diseases: carotid
(CA):71, subclavian (SA): 33, coronary: 75. Atheromatous lesions: 116,
inﬂammatory: 4. Mean lesion length: 9,5 þ/- 2,9 mm. Mean % stenosis
83.6  7.8, mean arterial diameter : 4,8  0,6 mm (4-6). 112 lesions at
VO segment (ostium), 6 at V1 and 2 at V2 segments. Indications for
angioplasty: dizziness (110), bilateral weakness (12), visual changes
14), diplopia (12), drop attacks (24), TIA (15), ataxia (6). A protection
device (ﬁlter) used in 12 pts. 25 SA angioplasties performed at the
same time of VAS, 10 CA. All angioplasties performed by femoral
approach, 4 by brachial approaches after failure of femoral approach.
(2 successes).
RESULTS Technical success 118/120 (99%). 6 lesions treated by an-
gioplasty alone: 3 VO (ﬁrst 3 pts. 2 V1, 1 V2 lesion). 1 pt (inﬂammatory
disease) treated by cutting balloon alone. 111 lesions treated with
stents (direct stenting: 96). Peripheral balloon expandable stents
(n¼23), self expandable stents (n¼4 for 3 V1 and one V2 lesions). 88
coronary stents (20 DES). 1 pt developed a TIA during the procedure.
No neurological complications at 30 days Clinical success 112/114
(99%) Post-procedure arterial diameter: 4,60  0,8 mm (4-6). Mean
residual stenosis 2,5  3,9 %. In 12 pts treated with protection devices,
visible debris removed in 9 (6 Filterwire, 2 Fibernet) 1 Angioguard
with the same amount of debris as during Carotid Stenting) 9 pts (8%)
developed a symptomatic restenosis during the follow-up (mean:
33.4.29.9 months), 3 after PTA alone, 5 after PTA and stent (1 oc-
clusion treated medically, 7 stenoses successfully treated with PTA).
No restenosis after DES implantation at 1 year.
CONCLUSIONS VAS can be performed safely and effectively with a
high technical success rate, a low complication rate, a low restenosis
rate and a durable clinical success in patients with symptomatic VA
stenosis. Stents seem to improve immediate and long-term results.
The role of protection devices and D.E.S has to be discussed.
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BACKGROUND To review feasibility, safety and long-term results of
subclavian artery angioplasty.
METHODS 407 patients (males: 245, mean age: 66.1  12 y) underwent
percutaneous treatment for subclavian artery (SA) occlusive disease
(stenosis: 295, occlusion: 112). Left: 312, Right: 95, Innominate Artery:
28. Etiology: atheromatous: 397, others: 10 (Takayasu: 6) Mean %
stenosis 83.4 þ/- 7.8. Mean lesion length: 23.9 þ/- 8.7 mm Indications
for treatment were upper limb ischemia (ULI) (n¼177) Vertebrobasilar
insufﬁciency (VBI) (n¼157), associated VBI and ULI (n¼123), coronary
steal syndrome (n¼20) asymptomatic patients with severe coronary
disease (n¼73) 39 patients had associated Vertebral Artery stenosis, 81
carotid stenoses. 337 prevertebral lesion, 45 post vertebral, both 25.
Access: femoral (n¼287), brachial (n¼81), both (n¼39). “Pull through
technique”: 8 cases. An isolated balloon angioplasty was performed in
59 cases and 348 stents were implanted (balloon expandable: 276, self
expandable: 72).
RESULTS Technical success was obtained in 387 lesions (95 %)
100% for stenoses. Only 92 occlusions were recanalized (82 %). Four
periprocedural events occurred (1.2 %), 1 major (fatal stroke), 1
T.I.A., 2 arterial thromboses. During the follow-up (mean follow-up:
75.7 months  38.5), we had 40 restenoses (10 %). 13 occurred
following angioplasty alone (18.8 %) and 27 following angioplasty
and stent implantation (7.8 %) (P<0.01). 10 were treated by new
angioplasty alone, 30 by repeat stent implantation. Primary (PI) and
secondary (PII) patencies on an intention to treat basis at 10-year
follow-up were 80.2 % and 86.5 % respectively. In patients without
initial stent placement, the rates were 67.5 % and 75.5 % while in
those with stents, the rates rose to 91.5 % and 98.2 % (P < 0.01). PI
for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8 %
with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively
(P < 0.02).CONCLUSIONS P.T.A. is currently the treatment of choice for sub-
clavian artery lesions. It is a safe and effective procedure associated
with low risks and good long-term results. Stents seem to limit the
restenosis rate and improve long-term results.
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BACKGROUND Decreased proximal aortic distensibility predicts all-
cause mortality and cardiovascular events. Radial aortic distensibility
is preserved after thoracic endovascular aortic repair (TEVAR), but its
impact on longitudinal aortic distensibility (LAD) has not yet been
elucidated. This study sought to quantify the impact of TEVAR and
stent-graft oversizing on LAD in an ex-vivo porcine model.
METHODS Twenty fresh thoracic porcine aortas were harvested and
connected to a ﬂow pump at body temperature. The anterior side of
each aorta was marked every 5 cm from the left subclavian artery till
the celiac trunk. LAD measurements were conducted through high-
deﬁnition imaging and custom developed software at ﬁve different
pressure levels (100, 120, 140, 160 and 180 mmHg), before and after
TEVAR with a 150 mm long stent-graft. Three groups of oversizing
were created (0-9%, 10-19%, and 20-29%). Uniaxial tensile testing was
conducted after the experiment to evaluate the elastic properties of
the porcine aortas in the proximal, central and distal zones, from both
circumferential and longitudinal fragments.
RESULTS After TEVAR, LAD decreased in the stented segments (11.9%
vs. 5.6%, p<0.001) and in the total aorta (11.4% vs. 7.0%, p<0.001,
Figure 1). The positive linear correlation between LAD and pressure
was reduced at 120 mmHg in the stented segments (2.0% vs. 0.9%,
p<0.001) and in the total aorta (2.0% vs. 1.4%, p¼0.002), and
remained signiﬁcant for all higher pressures (Figure 1). Stent-graft
oversizing did not affect the level of LAD reduction (p¼0.797).
Tensile testing conﬁrmed homogeneity of aortic biomechanical
responses with a mean peak stress to rupture of 1.40.4 MPa and a
coefﬁcient of variation of 0.3. Moreover, mean peak stress was
higher for the circumferential than for the longitudinal fragments in
all three zones (2.30.4 MPa vs. 1.40.4 MPa, p¼0.01).CONCLUSIONS In this ex-vivo experimental model, LAD of the
healthy thoracic aorta decreased after TEVAR. Such longitudinal
stiffening may impact cardiovascular function and increase the risk of
cardiovascular disease and TEVAR-related complications. This study
may serve as a base for future investigation on the impact of thoracic
aortic stent-grafts and the cardiovascular system, and might
contribute to future stent-graft design.
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